Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Nygren, P' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 97 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Martinsson, P; Liminga, G; Nygren, P; Larsson, R
      Characteristics of etoposide-induced apoptotic cell death in the U-937 human lymphoma cell line

      ANTI-CANCER DRUGS
    2. Hassan, SB; de la Torre, M; Nygren, P; Karlsson, MO; Larsson, R; Jonsson, E
      A hollow fiber model for in vitro studies of cytotoxic compounds: activityof the cyanoguanidine CHS 828

      ANTI-CANCER DRUGS
    3. Garcia, W; Nygren, P; Desfontaines, L
      Dynamics of nonstructural carbohydrates and biomass yield in a fodder legume tree at different harvest intensities

      TREE PHYSIOLOGY
    4. Jonsson, E; Friberg, LE; Karlsson, MO; Hassan, SB; Nygren, P; Kristensen, J; Tholander, B; Binderup, L; Larsson, R
      In vivo activity of CHS 828 on hollow-fibre cultures of primary human tumour cells from patients

      CANCER LETTERS
    5. Glimelius, B; Bergh, J; Brandt, L; Brorsson, B; Gunnars, B; Hafstrom, L; Haglund, U; Hogberg, T; Janunger, KG; Jonsson, PE; Karlsson, G; Kimby, E; Lamnevik, G; Nilsson, S; Permert, J; Ragnhammar, P; Sorenson, S; Nygren, P
      The Swedish Council on Technology Assessment in Health Care (SBU) systematic overview of chemotherapy effects in some major tumour types - Summary and conclusions

      ACTA ONCOLOGICA
    6. Nygren, P; Glimelius, B
      The Swedish Council on Technology Assessment in Health Care (SBU) report on cancer chemotherapy - Project objectives, the working process, key definitions and general aspects on cancer trial methodology and interpretation

      ACTA ONCOLOGICA
    7. Nygren, P
      What is cancer chemotherapy?

      ACTA ONCOLOGICA
    8. Gunnars, B; Nygren, P; Glimelius, B
      Assessment of quality of life during chemotherapy

      ACTA ONCOLOGICA
    9. Brandt, L; Kimby, E; Nygren, P; Glimelius, B
      A systematic overview of chemotherapy effects in Hodgkin's disease

      ACTA ONCOLOGICA
    10. Kimby, E; Brandt, L; Nygren, P; Glimelius, B
      A systematic overview of chemotherapy effects in aggressive non-Hodgkin's lymphoma

      ACTA ONCOLOGICA
    11. Brandt, L; Kimby, E; Nygren, P; Glimelius, B
      A systematic overview of chemotherapy effects in indolent non-Hodgkin's lymphoma

      ACTA ONCOLOGICA
    12. Kimby, E; Brandt, L; Nygren, P; Glimelius, B
      A systematic overview of chemotherapy effects in B-cell chronic lymphocytic leukaemia

      ACTA ONCOLOGICA
    13. Kimby, E; Nygren, P; Glimelius, B
      A systematic overview of chemotherapy effects in acute myeloid leukaemia

      ACTA ONCOLOGICA
    14. Bergh, J; Jonsson, PE; Glimelius, B; Nygren, P
      A systematic overview of chemotherapy effects in breast cancer

      ACTA ONCOLOGICA
    15. Ragnhammar, P; Hafstrom, L; Nygren, P; Glimelius, B
      A systematic overview of chemotherapy effects in colorectal cancer

      ACTA ONCOLOGICA
    16. Janunger, KG; Hafstrom, L; Nygren, P; Glimelius, B
      A systematic overview of chemotherapy effects in gastric cancer

      ACTA ONCOLOGICA
    17. Sorenson, S; Glimelius, B; Nygren, P
      A systematic overview of chemotherapy effects in non-small cell lung cancer

      ACTA ONCOLOGICA
    18. Hogberg, T; Glimelius, B; Nygren, P
      A systematic overview of chemotherapy effects in ovarian cancer

      ACTA ONCOLOGICA
    19. Permert, J; Hafstrom, L; Nygren, P; Glimelius, B
      A systematic overview of chemotherapy effects in pancreatic cancer

      ACTA ONCOLOGICA
    20. Nilsson, S; Ragnhammar, P; Glimelius, B; Nygren, P
      A systematic overview of chemotherapy effects in urothelial bladder cancer

      ACTA ONCOLOGICA
    21. Ragnhammar, P; Brorsson, B; Nygren, P; Glimelius, B
      A prospective study of the use of chemotherapy in Sweden and assessment ofthe use in relation to scientific evidence

      ACTA ONCOLOGICA
    22. Karlsson, G; Nygren, P; Glimelius, B
      Economic aspects of chemotherapy

      ACTA ONCOLOGICA
    23. Salas, E; Nygren, P; Domenach, AM; Berninger, F; Ramirez, C
      Estimating biological N-2 fixation by a tropical legume tree using the non-nodulating phenophase as the reference in the N-15 natural abundance method

      SOIL BIOLOGY & BIOCHEMISTRY
    24. Ekelund, S; Sjoholm, A; Nygren, P; Binderup, L; Larsson, R
      Cellular pharmacodynamics of the cytotoxic guanidino-containing drug CHS 828. Comparison with methylglyoxal-bis(guanplhydrazone)

      EUROPEAN JOURNAL OF PHARMACOLOGY
    25. Martinsson, P; de la Torre, M; Binderup, L; Nygren, P; Larsson, R
      Cell death with atypical features induced by the novel antitumoral drug CHS 828, in human U-937 GTB cells

      EUROPEAN JOURNAL OF PHARMACOLOGY
    26. Ekelund, S; Nygren, P; Larsson, R
      Guanidino-containing drugs in cancer chemotherapy: biochemical and clinical pharmacology

      BIOCHEMICAL PHARMACOLOGY
    27. Sievanen, R; Nikinmaa, E; Nygren, P; Ozier-Lafontaine, H; Perttunen, J; Hakula, H
      Components of functional-structural tree models

      ANNALS OF FOREST SCIENCE
    28. Dhar, S; Gullbo, J; Csoka, K; Eriksson, E; Nilsson, K; Nickel, P; Larsson, R; Nygren, P
      Antitumour activity of suramin analogues in human tumour cell lines and primary cultures of tumour cells from patients

      EUROPEAN JOURNAL OF CANCER
    29. Jonsson, E; Dhar, S; Jonsson, B; Nygren, P; Graf, W; Larsson, R
      Differential activity of topotecan, irinotecan and SN-38 in fresh human tumour cells but not in cell lines

      EUROPEAN JOURNAL OF CANCER
    30. von Heideman, A; Sandstrom, M; Csoka, K; Tholander, B; Larsson, R; Bergh, J; Nygren, P
      Evaluation of drug interactions in the established FEC regimen in primary cultures of tumour cells from patients

      ANNALS OF ONCOLOGY
    31. Frost, BM; Gustafsson, G; Larsson, R; Nygren, P; Lonnerholm, G
      Cellular cytotoxic drug sensitivity in children with acute leukemia and Down's syndrome: an explanation to differences in clinical outcome?

      LEUKEMIA
    32. Nygren, P; Vaillant, V; Desfontaines, L; Cruz, P; Domenach, AM
      Effects of nitrogen source and defoliation on growth and biological dinitrogen fixation of Gliricidia sepium seedlings

      TREE PHYSIOLOGY
    33. Nygren, P; Cruz, P; Domenach, AM; Vaillant, V; Sierra, J
      Influence of forage harvesting regimes on dynamics of biological dinitrogen fixation of a tropical woody legume

      TREE PHYSIOLOGY
    34. Nygren, P; Lorenzo, A; Cruz, P
      Decomposition of woody legume nodules in two tree/grass associations undercontrasting environmental conditions

      AGROFORESTRY SYSTEMS
    35. Berninger, F; Nikinmaa, E; Sievanen, R; Nygren, P
      Modelling of reserve carbohydrate dynamics, regrowth and nodulation in a N-2-fixing tree managed by periodic prunings

      PLANT CELL AND ENVIRONMENT
    36. Liminga, G; Martinsson, P; Jonsson, B; Nygren, P; Larsson, R
      Apoptosis induced by calcein acetoxymethyl ester in the human histiocytic lymphoma cell line U-937 GTB

      BIOCHEMICAL PHARMACOLOGY
    37. Fridborg, H; Jonsson, E; Nygren, P; Larsson, R
      Relationship between diagnosis-specific activity of cytotoxic drugs in fresh human tumour cells ex vivo and in the clinic

      EUROPEAN JOURNAL OF CANCER
    38. Karlsson, MO; Molnar, V; Freijs, A; Nygren, P; Bergh, J; Larsson, R
      Pharmacokinetic models for the saturable distribution of paclitaxel

      DRUG METABOLISM AND DISPOSITION
    39. Nygren, P; Csoka, K; Larsson, R; Busch, C; Wester, K; Malmstrom, PU
      Activity of standard and investigational cytotoxic drugs in primary cultures of tumor cells from patients with kidney and urinary bladder carcinomas

      JOURNAL OF UROLOGY
    40. Liminga, G; Jonsson, B; Nygren, P; Larsson, R
      On the mechanism underlying calcein-induced cytotoxicity

      EUROPEAN JOURNAL OF PHARMACOLOGY
    41. DHAR S; GULLBO J; NILSSON K; NYGREN P; LARSSON R
      A NONCLONOGENIC CYTOTOXICITY ASSAY USING PRIMARY CULTURES OF PATIENT TUMOR-CELLS FOR ANTICANCER DRUG SCREENING

      Journal of biomolecular screening
    42. EKELUND S; NYGREN P; LARSSON R
      MICROPHYSIOMETRY - NEW TECHNOLOGY FOR EVALUATION OF ANTICANCER DRUG ACTIVITY IN HUMAN TUMOR-CELLS IN-VITRO

      Anti-cancer drugs
    43. DHAR S; LARSSON R; NYGREN P; EHRSSON H; LEWENSOHN R
      CYTOTOXIC ACTIVITY OF L-PROLYL-M-L-SARCOLYSYL-L-P-FLUOROPHENYLALANINEIN HUMAN TUMOR-CELLS

      Annals of oncology
    44. LIMINGA G; NYGREN P; LARSSON R
      CHARACTERIZATION OF CALCEIN AMS CYTOTOXIC ACTIVITY ON HUMAN TUMOR-CELL LINES/

      Annals of oncology
    45. EKELUND S; NYGREN P; LARSSON R
      CANCER DRUG DEVELOPMENT AND EVALUATION - APPLICATION OF THE CYTOSENSOR MICROPHYSIOMETER

      Annals of oncology
    46. Saur, E; Bonheme, I; Nygren, P; Imbert, D
      Nodulation of Pterocarpus officinalis in the swamp forest of Guadeloupe (Lesser Antilles)

      JOURNAL OF TROPICAL ECOLOGY
    47. Nygren, P; Cruz, P
      Biomass allocation and nodulation of Gliricidia sepium under two cut-and-carry forage production regimes

      AGROFORESTRY SYSTEMS
    48. JONSSON E; FRIDBORG H; NYGREN P; LARSSON R
      SYNERGISTIC INTERACTIONS OF COMBINATIONS OF TOPOTECAN WITH STANDARD DRUGS IN PRIMARY CULTURES OF HUMAN TUMOR-CELLS FROM PATIENTS

      European Journal of Clinical Pharmacology
    49. DHAR S; NYGREN P; LIMINGA G; SUNDSTROM C; DELATORRE M; NILSSON K; LARSSON R
      RELATIONSHIP BETWEEN CYTOTOXIC DRUG RESPONSE PATTERNS AND ACTIVITY OFDRUG EFFLUX TRANSPORTERS MEDIATING MULTIDRUG-RESISTANCE

      European journal of pharmacology
    50. LARSSON R; DHAR S; EHRSSON H; NYGREN P; LEWENSOHN R
      COMPARISON OF THE CYTOTOXIC ACTIVITY OF MELPHALAN WITH L-PROLYL-M-L-SARCOLYSYL-L-P-FLUOROPHENYLALANINE IN HUMAN TUMOR-CELL LINES AND PRIMARY CULTURES OF TUMOR-CELLS FROM PATIENTS

      British Journal of Cancer
    51. VAGHEF H; NYGREN P; EDLING C; BERGH J; HELLMAN B
      ALKALINE SINGLE-CELL GEL-ELECTROPHORESIS AND HUMAN BIOMONITORING FOR GENOTOXICITY - A PILOT-STUDY ON BREAST-CANCER PATIENTS UNDERGOING CHEMOTHERAPY INCLUDING CYCLOPHOSPHAMIDE

      Mutation research. Genetic toxicology and environmental mutagenesis
    52. NYGREN P; KIEMA P; REBOTTARO S
      CANOPY DEVELOPMENT, CO2 EXCHANGE AND CARBON BALANCE OF A MODELED AGROFORESTRY TREE (VOL 16, PG 733, 1996)

      Tree physiology
    53. KASS DCL; SYLVESTERBRADLEY R; NYGREN P
      THE ROLE OF NITROGEN-FIXATION AND NUTRIENT SUPPLY IN SOME AGROFORESTRY SYSTEMS OF THE AMERICA

      Soil biology & biochemistry
    54. MARTINSSON P; NYGREN P; FRIDBORG H; NILSSON K; KRISTENSEN J; LARSSON R
      CYTOTOXIC ACTIVITY OF CYCLOSPORINE-A AND [3-KETO-BMT(1)]-[VAL(2)]-CYCLOSPORINE (SDZ-PSC-833) ON TUMOR-CELLS FROM PATIENTS WITH HEMATOLOGICAL MALIGNANCIES

      European Journal of Clinical Pharmacology
    55. CSOKA K; THOLANDER B; GERDIN E; DELATORRE M; LARSSON R; NYGREN P
      IN-VITRO DETERMINATION OF CYTOTOXIC DRUG RESPONSE IN OVARIAN-CARCINOMA USING THE FLUOROMETRIC MICROCULTURE CYTOTOXICITY ASSAY (FMCA)

      International journal of cancer
    56. CSOKA K; DHAR S; FRIDBORG H; LARSSON R; NYGREN P
      DIFFERENTIAL ACTIVITY OF CREMOPHOR EL AND PACLITAXEL IN PATIENTS TUMOR-CELLS AND HUMAN CARCINOMA CELL-LINES IN-VITRO

      Cancer
    57. JONSSON E; FRIDBORG H; CSOKA K; DHAR S; SUNDSTROM C; NYGREN P; LARSSON R
      CYTOTOXIC ACTIVITY OF TOPOTECAN IN HUMAN TUMOR-CELL LINES AND PRIMARYCULTURES OF HUMAN TUMOR-CELLS FROM PATIENTS

      British Journal of Cancer
    58. JONSSON B; LIMINGA G; CSOKA K; FRIDBORG H; DHAR S; NYGREN P; LARSSON R
      CYTOTOXIC ACTIVITY OF CALCEIN ACETOXYMETHYL ESTER (CALCEIN AM) ON PRIMARY CULTURES OF HUMAN HEMATOLOGICAL AND SOLID TUMORS/

      European journal of cancer
    59. NYGREN P; KIEMA P; REBOTTARO S
      CANOPY DEVELOPMENT, CO2 EXCHANGE AND CARBON BALANCE OF A MODELED AGROFORESTRY TREE

      Tree physiology
    60. SANDSTROM M; FREIJS A; LARSSON R; NYGREN P; FJALLSKOG ML; BERGH J; KARLSSON MO
      LACK OF RELATIONSHIP BETWEEN SYSTEMIC EXPOSURE FOR THE COMPONENT DRUGS OF THE FLUOROURACIL, EPIRUBICIN, AND 4-HYDROXYCYCLOPHOSPHAMIDE REGIMEN IN BREAST-CANCER PATIENTS

      Journal of clinical oncology
    61. PESTANA ES; BJORKLUND G; LARSSON R; NYGREN P; NILSSON K; BERGH J
      EFFECTS OF INTERFERONS AND TUMOR-NECROSIS-FACTOR-ALPHA ON HUMAN LUNG-CANCER CELL-LINES AND THE DEVELOPMENT OF AN INTERFERON-RESISTANT LUNG-CANCER CELL-LINE

      Acta oncologica
    62. RIDEFELT P; LARSSON R; NYGREN P; LARSSON E; NILSSON K
      MODULATION OF CALCIUM SIGNALING AND PROLIFERATION IN MONOBLASTOID U-937 CELLS

      Anticancer research
    63. DHAR S; NYGREN P; CSOKA K; BOTLING J; NILSSON K; LARSSON R
      ANTICANCER DRUG CHARACTERIZATION USING A HUMAN CELL-LINE PANEL REPRESENTING DEFINED TYPES OF DRUG-RESISTANCE

      British Journal of Cancer
    64. LIMINGA G; NYGREN P; DHAR S; NILSSON K; LARSSON R
      CYTOTOXIC EFFECT OF CALCEIN ACETOXYMETHYL ESTER ON HUMAN TUMOR-CELL LINES - DRUG-DELIVERY BY INTRACELLULAR TRAPPING

      Anti-cancer drugs
    65. FRIDBORG H; NYGREN P; LARSSON R
      RELATIONSHIP BETWEEN PHARMACOKINETIC PARAMETERS IN PATIENTS AND CYTOTOXICITY IN-VITRO OF STANDARD AND INVESTIGATIONAL ANTICANCER DRUGS

      Anti-cancer drugs
    66. NYGREN P
      LEAF CO2 EXCHANGE OF ERYTHRINA-POEPPIGIANA (LEGUMINOSAE, PHASEOLAE) IN HUMID TROPICAL FIELD CONDITIONS

      Tree physiology
    67. NYGREN P; RAMIREZ C
      PRODUCTION AND TURNOVER OF N-2 FIXING NODULES IN RELATION TO FOLIAGE DEVELOPMENT IN PERIODICALLY PRUNED ERYTHRINA-POEPPIGIANA (LEGUMINOSAE)TREES

      Forest ecology and management
    68. NYGREN P
      ABOVEGROUND NITROGEN DYNAMICS FOLLOWING THE COMPLETE PRUNING OF A NODULATED WOODY LEGUME IN HUMID TROPICAL FIELD CONDITIONS

      Plant, cell and environment
    69. CSOKA K; LILIEMARK J; LARSSON R; NYGREN P
      EVALUATION OF THE CYTOTOXIC ACTIVITY OF GEMCITABINE IN PRIMARY CULTURES OF TUMOR-CELLS FROM PATIENTS WITH HEMATOLOGIC OR SOLID TUMORS

      Seminars in oncology
    70. DELATORRE M; NYGREN P; LARSSON R; LINDGREN A; TSURUO T; BERGH J
      EXPRESSION OF THE 85-KD MEMBRANE-PROTEIN IN PRIMARY HUMAN BREAST-CANCER - RELATIONSHIP TO HORMONE-RECEPTOR LEVELS, DNA-PLOIDY, AND TUMOR GRADE

      Human pathology
    71. CSOKA K; NYGREN P; GRAF W; PAHLMAN L; GLIMELIUS B; LARSSON R
      SELECTIVE SENSITIVITY OF SOLID TUMORS TO SURAMIN IN PRIMARY CULTURES OF TUMOR-CELLS FROM PATIENTS

      International journal of cancer
    72. NYGREN P; CSOKA K; JONSSON B; FRIDBORG H; BERGH J; HAGBERG H; GLIMELIUS B; BRODIN O; THOLANDER B; KREUGER A; LONNERHOLM G; JAKOBSSON A; OLSEN L; KRISTENSEN J; LARSSON R
      CYTOTOXIC ACTIVITY OF TAXOL IN PRIMARY CULTURES OF TUMOR-CELLS FROM PATIENTS IS PARTLY MEDIATED BY CREMOPHOR EL

      British Journal of Cancer
    73. BACKLIN C; FRIDBORG H; JUHLIN C; NYGREN P; AKERSTROM G; RASTAD J; LARSSON R
      VARIABLE P-GLYCOPROTEIN IMMUNOREACTIVITY UNRELATED TO CYTOTOXIC DRUG-RESISTANCE IN-VITRO OF HUMAN ADRENOCORTICAL CARCINOMA

      International journal of oncology
    74. LARSSON R; FRIDBORG H; LILIEMARK J; CSOKA K; KRISTENSEN J; DELATORRE M; NYGREN P
      IN-VITRO ACTIVITY OF 2-CHLORODEOXYADENOSINE (CDA) IN PRIMARY CULTURESOF HUMAN HEMATOLOGICAL AND SOLID TUMORS

      European journal of cancer
    75. HOLMBERG M; SANDBERG C; NYGREN P; LARSSON R
      EFFECTS OF LOVASTATIN ON A HUMAN MYELOMA CELL-LINE - INCREASED SENSITIVITY OF A MULTIDRUG-RESISTANT SUBLINE THAT EXPRESSES THE 170-KDA P-GLYCOPROTEIN

      Anti-cancer drugs
    76. NYGREN P; HAGBERG H; GLIMELIUS B; SUNDSTROM C; KRISTENSEN J; CHRISTIANSEN I; LARSSON R
      IN-VITRO DRUG-SENSITIVITY TESTING OF TUMOR-CELLS FROM PATIENTS WITH NON-HODGKINS-LYMPHOMA USING THE FLUOROMETRIC MICROCULTURE CYTOTOXICITY ASSAY

      Annals of oncology
    77. GRUBER A; LARSSON R; NYGREN P; BJORKHOLM M; PETERSON C
      A NON-P-GLYCOPROTEIN-MEDIATED MECHANISM OF VINCRISTINE TRANSPORT WHICH IS AFFECTED BY RESISTANCE MODIFIERS AND PRESENT IN CHEMOSENSITIVE CELLS

      Leukemia
    78. KRISTENSEN J; NYGREN P; LILIEMARK J; FRIDBORG H; KILLANDER A; SIMONSSON B; OBERG G; LARSSON R
      INTERACTIONS BETWEEN CLADRIBINE (2-CHLORODEOXYADENOSINE) AND STANDARDANTILEUKEMIC DRUGS IN PRIMARY CULTURES OF HUMAN TUMOR-CELLS FROM PATIENTS WITH ACUTE MYELOCYTIC-LEUKEMIA

      Leukemia
    79. SJOHOLM A; BUCHT E; THEODORSSON E; LARSSON R; NYGREN P
      POLYAMINES REGULATE HUMAN MEDULLARY-THYROID CARCINOMA TT-CELL PROLIFERATION AND SECRETION OF CALCITONIN AND CALCITONIN-GENE-RELATED PEPTIDE

      Molecular and cellular endocrinology
    80. DELATORRE M; LARSSON R; NYGREN P; LINDGREN A; BERGH J
      EXPRESSION OF THE MULTIDRUG-RESISTANCE GENE-PRODUCT IN UNTREATED HUMAN BREAST-CANCER AND ITS RELATIONSHIP TO PROGNOSTIC MARKERS

      Acta oncologica
    81. FRIDBORG H; LARSSON R; JUHLIN C; RASTAD J; AKERSTROM G; BACKLIN K; NYGREN P
      P-GLYCOPROTEIN EXPRESSION AND ACTIVITY OF RESISTANCE MODIFYING AGENTSIN PRIMARY CULTURES OF HUMAN RENAL AND ADRENOCORTICAL CARCINOMA-CELLS

      Anticancer research
    82. CSOKA K; LARSSON R; THOLANDER B; GERDIN E; DELATORRE M; NYGREN P
      CYTOTOXIC DRUG-SENSITIVITY TESTING OF TUMOR-CELLS FROM PATIENTS WITH OVARIAN-CARCINOMA USING THE FLUOROMETRIC MICROCULTURE CYTOTOXICITY ASSAY (FMCA)

      Gynecologic oncology
    83. NYGREN P; HARI P; RAUNEMAA T; KULMALA M; LUOKKANEN S; HOLMBERG M; NIKINMAA E
      BEHAVIOR OF CS-137 FROM CHERNOBYL FALLOUT IN A SCOTS PINE CANOPY IN SOUTHERN FINLAND

      Canadian journal of forest research
    84. BOTLING J; LIMINGA G; LARSSON R; NYGREN P; NILSSON K
      DEVELOPMENT OF VINCRISTINE RESISTANCE AND INCREASED SENSITIVITY TO CYCLOSPORINE-A AND VERAPAMIL IN THE HUMAN U-937 LYMPHOMA CELL-LINE WITHOUT OVEREXPRESSION OF THE 170-KDA P-GLYCOPROTEIN

      International journal of cancer
    85. NYGREN P; FRIDBORG H; CSOKA K; SUNDSTROM C; DELATORRE M; KRISTENSEN J; BERGH J; HAGBERG H; GLIMELIUS B; RASTAD J; THOLANDER B; LARSSON R
      DETECTION OF TUMOR-SPECIFIC CYTOTOXIC DRUG ACTIVITY IN-VITRO USING THE FLUOROMETRIC MICROCULTURE CYTOTOXICITY ASSAY AND PRIMARY CULTURES OFTUMOR-CELLS FROM PATIENTS

      International journal of cancer
    86. LIMINGA G; NYGREN P; LARSSON R
      MICROFLUOROMETRIC EVALUATION OF CALCEIN ACETOXYMETHYL ESTER AS A PROBE FOR P-GLYCOPROTEIN-MEDIATED RESISTANCE - EFFECTS OF CYCLOSPORINE-A AND ITS NONIMMUNOSUPPRESSIVE ANALOG SDZ-PSC-833

      Experimental cell research
    87. LARSSON R; NYGREN P
      CYTOTOXIC ACTIVITY OF TOPOISOMERASE-II INHIBITORS IN PRIMARY CULTURESOF TUMOR-CELLS FROM PATIENTS WITH HUMAN HEMATOLOGIC AND SOLID TUMORS

      Cancer
    88. FRIDBORG H; JONSSON B; NYGREN P; CSOKA K; NILSSON K; OBERG G; KRISTENSEN J; BERGH J; THOLANDER B; OLSEN L; JAKOBSON A; LARSSON R
      ACTIVITY OF CYCLOSPORINES AS RESISTANCE MODIFIERS IN PRIMARY CULTURESOF HUMAN HEMATOLOGICAL AND SOLID TUMORS

      British Journal of Cancer
    89. LARSSON R; NYGREN P
      LABORATORY PREDICTION OF CLINICAL CHEMOTHERAPEUTIC DRUG-RESISTANCE - A WORKING MODEL EXEMPLIFIED BY ACUTE-LEUKEMIA

      European journal of cancer
    90. LARSSON R; NYGREN P
      PREDICTION OF INDIVIDUAL PATIENT RESPONSE TO CHEMOTHERAPY BY THE FLUOROMETRIC MICROCULTURE CYTOTOXICITY ASSAY (FMCA) USING DRUG-SPECIFIC CUTOFF LIMITS AND A BAYESIAN MODEL

      Anticancer research
    91. DELATORRE M; HAO XY; LARSSON R; NYGREN P; TSURUO T; MANNERVIK B; BERGH J
      CHARACTERIZATION OF 4 DOXORUBICIN ADAPTED HUMAN BREAST-CANCER CELL-LINES WITH RESPECT TO CHEMOTHERAPEUTIC DRUG-SENSITIVITY, DRUG-RESISTANCEASSOCIATED MEMBRANE-PROTEINS AND GLUTATHIONE TRANSFERASES

      Anticancer research
    92. SJOHOLM A; LARSSON R; NYGREN P
      DIFLUOROMETHYLORNITHINE AND ETHYLGLYOXAL BIS(GUANYLHYDRAZONE) AS INHIBITORS OF HUMAN RENAL-CARCINOMA CELL-PROLIFERATION AND POLYAMINE METABOLISM

      Anticancer research
    93. NYGREN P; REBOTTARO S; CHAVARRIA R
      APPLICATION OF THE PIPE MODEL-THEORY TO NONDESTRUCTIVE ESTIMATION OF LEAF BIOMASS AND LEAF-AREA OF PRUNED AGROFORESTRY TREES

      Agroforestry systems
    94. NYGREN P; JIMENEZ JM
      RADIATION REGIME AND NITROGEN SUPPLY IN MODELED ALLEY CROPPING SYSTEMS OF ERYTHRINA-POEPPIGIANA WITH SEQUENTIAL MAIZE BEAN CULTIVATION

      Agroforestry systems
    95. NYGREN P; MARAUX F; SANCHEZ GA
      SOLAR-RADIATION TRANSMISSION IN THE CANOPY OF ERYTHRINA-POEPPIGIANA (WALPERS) COOK,O.F.

      Pesquisa agropecuaria brasileira
    96. NYGREN P
      SIMULATION OF THE SHADING PATTERN OF PERIODICALLY PRUNED TREES IN AGROFORESTRY SYSTEMS

      Pesquisa agropecuaria brasileira
    97. LARSSON R; FRIDBORG H; KRISTENSEN J; SUNDSTROM C; NYGREN P
      INVITRO TESTING OF CHEMOTHERAPEUTIC DRUG-COMBINATIONS IN ACUTE MYELOCYTIC-LEUKEMIA USING THE FLUOROMETRIC MICROCULTURE CYTOTOXICITY ASSAY (FMCA)

      British Journal of Cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/05/20 alle ore 03:55:03